Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

544
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
544
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

622
The pathophysiology of pneumonia involves the following steps:
622
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

300
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
300

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same author

Gut-derived, inflammatory ILC2s disseminate type 2 immunity to remote lung in food allergen-challenged mice.

Journal of leukocyte biology·2026
Same author

Single-cell analysis of recruited ILC2 cell fate during transition from circulation to establishment of tissue residency.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Sprouty2 modulates NF-κB signaling by sequestering the phosphatase PP2Ac in LPS-stimulated macrophages.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

CBX7 functions as a methylation-dependent inducer of gene transcription and regulator of cytosolic signaling in lymphoid cells.

Science advances·2026
Same author

Allergens abrogate antiinflammatory DNA effects and unmask macrophage-driven neutrophilic asthma via ILC2/STING/TNF-α signaling.

The Journal of clinical investigation·2025

Related Experiment Video

Updated: Sep 19, 2025

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

2.1K

ILC2 Diversity, Location, and Function in Pulmonary Disease.

Mukesh Verma1, Uryan I Can1, R Lee Reinhardt1,2

  • 1Department of Immunology and Genomic Medicine, National Jewish Health, Denver, Colorado, USA.

Immunological Reviews
|June 2, 2025
PubMed
Summary
This summary is machine-generated.

Group 2 innate lymphoid cells (ILC2) are crucial early producers of type-2 cytokines, driving lung inflammation and disease. This review details ILC2 origins, heterogeneity, and their impact on pulmonary conditions.

Keywords:
COPDILC2asthmaimmune‐mediated diseasesinfectious diseaseslungparasitic‐helminthtissuesviral

More Related Videos

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

7.0K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.4K

Related Experiment Videos

Last Updated: Sep 19, 2025

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

2.1K
Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

7.0K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.4K

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Type-2 inflammation, characterized by IL-4, IL-5, and IL-13, underlies key lung responses like mucus production and immune cell recruitment.
  • Group 2 innate lymphoid cells (ILC2) are pivotal early sources of these type-2 cytokines, significantly influencing immune responses in the lung.
  • ILC2 activity is linked to the 'weep-and-sweep' responses in mucosal tissues following epithelial damage.

Purpose of the Study:

  • To review the multifaceted role of ILC2 in lung immunity and disease.
  • To explore the origins of ILC2 within the context of the gut-lung axis.
  • To examine the heterogeneity of ILC2 populations and their impact on pulmonary pathologies.

Main Methods:

  • This is a review article, synthesizing existing research on ILC2 function in the lung.
  • The review focuses on analyzing data related to ILC2 origins, heterogeneity, activation, migration, and intercellular communication.
  • Literature search and critical analysis of studies investigating ILC2 in pulmonary contexts.

Main Results:

  • ILC2 are critical regulators of type-2 inflammation in the lung, originating from the gut-lung axis.
  • Distinct circulating and tissue-resident ILC2 populations exhibit unique characteristics and functions.
  • ILC2 behavior, including activation, migration, and environmental interactions, significantly influences pulmonary disease progression.

Conclusions:

  • ILC2 are essential immune cells in the lung, impacting the development and severity of various pulmonary diseases.
  • Understanding ILC2 heterogeneity and their regulatory mechanisms is key to developing targeted therapies.
  • Further research into the gut-lung axis and ILC2 communication networks will illuminate their broader role in respiratory health.